Hispanic and Black men are dying from HPV-associated throat cancer at a higher rate, and most new cases are being diagnosed in white men at late-stage when it’s more difficult to treat, according to a new Rutgers study. The research published in the Annals of Cancer Epidemiology is the largest and most comprehensive population-based study of its kind.

“Since these oropharyngeal cancers are all potentially preventable through the administration of the HPV vaccine, public health campaigns are needed to increase awareness of HPV’s link to throat cancer, its signs and symptoms, and to promote uptake of HPV vaccinations in all adolescent and young adult males,” said Jeanne Ferrante, the study’s senior author and professor in the Department of Family Medicine and Community Health at Rutgers Robert Wood Johnson Medical School. “In addition, clinicians need to be aware of who is at risk and the common clinical presentations.” To read the full story.